Plasma oxidizability in Mexican-Americans and non-Hispanic whites

Metabolism: Clinical and Experimental

Volumn 45, Issue 7, 1996, Pages 876-881

  Haffner, Steven M ^a   Miettinen, Heikki ^b   Stern, Michael P ^b   Agil, Ahmad ^b   Jialal, Ishwarlal ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY RISK; DIABETES MELLITUS; ETHNIC GROUP; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPID OXIDATION; MALE; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

EID: 0029951361     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90163-8     Document Type: Article

References (47)

1. Haffner SM, Hazuda HP, Mitchell BD, et al: Increased incidence of type II diabetes mellitus in Mexican Americans. Diabetes Care 14:102-108, 1991
2. Stern MP, Rosenthal M, Haffner SM, et al: Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: The San Antonio Heart Study. Am J Epidemiol 120:834-851, 1984
3. Haffner SM, Stern MP, Hazuda HP, et al: Upper body adiposity and centralized adiposity in Mexican Americans and non-Hispanic whites: Relationship to body mass index and other behavioral and demographic variables. Int J Obes 10:493-502, 1986
4. Haffner SM, Stern MP, Hazuda HP, et al: Hyperinsulinemia in a population at high risk for non-insulin dependent diabetes mellitus. N Engl J Med 315:220-224, 1986
5. Haffner SM, Stern MP, Dunn JF, et al: Diminished insulin sensitivity and increased insulin response in non-obese, non-diabetic Mexican Americans. Metabolism 39:842-847, 1990
6. Haffner SM, Stern MP, Hazuda HP, et al: The role of behavioral variables, and fat patterning in explaining ethnic differences in serum lipids and lipoproteins. Am J Epidemiol 123:830-839, 1986
7. Haffner SM, Mitchell BD, Stern MP, et al: Decreased prevalence of hypertension in Mexican Americans. Hypertension 16:225-232, 1990
8. Mitchell BD, Stern MP, Haffner SM, et al: Risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites: The San Antonio Heart Study. Am J Epidemiol 131:423-433, 1990
9. Stern MP, Bradshaw BS, Eifler CW, et al: Secular decline in death rates due to ischemic heart disease in Mexican Americans and non-Hispanic whites in Texas, 1970-1980. Circulation 76:1245-1250, 1987
10. Mitchell BD, Hazuda HP, Haffner SM, et al: Myocardial infarction in Mexican Americans and non-Hispanic whites: The San Antonio Heart Study. Circulation 83:45-51, 1991
11. Rewers M, Shetterly SM, Baxter J, et al: Prevalence of coronary heart disease in subjects with normal and impaired glucose tolerance and non-insulin dependent diabetes mellitus in a biethnic Colorado population. The San Luis Valley Diabetes Study. Am J Epidemiol 135:1321-1330, 1992
12. Orlander PR, Goff DC, Morrissey M, et al: The relationship of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican Americans and non-Hispanic whites. The Corpus Christi Heart Project. Diabetes 43:897-902, 1994
13. Haffner SM, Gruber KK, Morales PA, et al: Lipoprotein(a) concentrations in Mexican Americans and non-Hispanic whites: The San Antonio Heart Study. Am J Epidemiol 136:1060-1068, 1992
14. Haffner SM, Mykkänen L, Valdez RA, et al: LDL size and subclass pattern in a biethnic population. Arterioscler Thromb 13:1623-1630, 1993
15. de Graaf J, Hak-Lemmers HLM, Hectors MPC, et al: Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 11:298-306, 1991
16. Tribble DL, Holl LG, Wood PD, et al: Variations in oxidative susceptibility among six low density lipoprotein subtractions of differing density and particle size. Atherosclerosis 93:189-199, 1992
17. Witztum JL, Steinberg D: Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88:1785-1792, 1991
18. Ylä-Herttuala S, Palinski W, Rosenfeld ME, et al: Evidence for the presence of oxidatively modified LDL in atherosclerotic lesions of rabbit and man. J Clin Invest 84:1086-1095, 1989
19. Salonen JT, Ylä-Herttuala S, Yamamoto R, et al: Autoantibody against oxidized low density lipoprotein and progression of carotid atherosclerosis. Lancet 339:883-887, 1992
20. Kita T, Nagano Y, Yokode M, et al: Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA 84:5928-5931, 1987
21. Stampfer MJ, Hennekens CH, Manson JE, et al: Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 328:1444-1449, 1993
22. Rimm EB, Stampfer MJ, Ascherio A, et al: Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328:1450-1456, 1993
23. Agil A, Fuller CJ, Jialal I: Susceptibility of plasma to ferrous iron/hydrogen peroxide-mediated oxidation: Demonstration of a possible Fenton reaction. Clin Chem 41:220-225, 1995
24. Yagi K: Lipid peroxides and human diseases. Chem Phys Lipids 45:337-351, 1987
25. Stringer MD, Görög PG, Freeman A, et al: Lipid peroxides and atherosclerosis. Br Med J 298:281-284, 1989
26. Hazuda HP, Comeaux PJ, Stern MP, et al: A comparison of three indicators for identifying Mexican Americans in epidemiologic research: Methodological findings from the San Antonio Heart Study. Am J Epidemiol 123:96-112, 1986
27. World Health Organization Expert Committee on Diabetes Mellitus. Second Report. Geneva, Switzerland, World Health Organization, 1982, pp 125-143
28. Frei B, England L, Ames BN: Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 86:6377-6381, 1989
29. Therasse J, Lemonnier F: Determination of plasma lipoperoxides by high performance liquid chromatography. J Chromatogr 413:237-241, 1987
30. Arnaud J, Fortis I, Blachier S, et al: Simultaneous determination of retinol, α-tocopherol and β-carotene in serum by isocratic high-performance liquid chromatography. J Chromatogr 572:103-116, 1991
31. Schmuck A, Fuller CJ, Devaraj S, et al: Effect of aging on susceptibility of low-density lipoproteins to oxidation. Clin Chem 41:1628-1632, 1995
32. Thurnham D, Davies J, Crump B, et al: The use of different lipids to express serum tocopherol: Lipid ratios for the measurement of vitamin E status. Ann Clin Biochem 23:514-520, 1986
33. Lepage G, Roy CC: Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27:114-120, 1986
34. Nishigaki I, Hagihara M, Tsunekawa H, et al: Lipid peroxide levels of serum lipoprotein fractions of diabetic patients. Biochem Med 25:373-378, 1981
35. Mooradian AD: Increased serum conjugated dienes in elderly diabetic patients. J Am Geriatr Soc 39:571-574, 1991
36. Haffner SM, Agil A, Mykkänen L, et al: Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance and NIDDM. Diabetes Care 18:646-653, 1995
37. Sato Y, Hotta N, Sakamoto N, et al: Lipid peroxide level in plasma of diabetic patients. Biochem Med 21:104-107, 1979
38. Kaji H, Kurasaki M, Ito K, et al: Increased lipoperoxide value and glutathione peroxidase activity in blood plasma of type 2 (non-insulin-dependent) diabetic women. Klin Wochenschr 63:765-768, 1985
39. Jennings PE, Jones AF, Florkowski CM, et al: Increased diene conjugates in diabetic subjects with microangiopathy. Diabetic Med 4:452-456, 1987
40. MacRury SM, Gordon D, Wilson R, et al: A comparison of different methods of assessing free radical activity in type 2 diabetes and peripheral vascular disease. Diabetic Med 10:331-335, 1993
41. Altamore E, Vendemaille G, Chicco D, et al: Increased lipid peroxide in type 2 poorly controlled diabetic patients. Diabete Metab 18:264-271, 1992
42. Velazquez E, Winocour PH, Kesteven P, et al: Relation of lipid peroxides to macrovascular disease in type 2 diabetes. Diabetic Med 8:752-758, 1991
43. Chisolm GM, Irwin KC, Penn MS: Lipoprotein oxidation and lipoprotein-induced cell injury in diabetes. Diabetes 41:61-66, 1992 (suppl 2)
44. Lyons TJ: Glycation and oxidation: A role in the pathogenesis of atherosclerosis. Am J Cardiol 71:26B-31B, 1993
45. Evans RW, Orchard TJ: Oxidized lipids in insulin-dependent diabetes mellitus: A sex-diabetes interaction? Metabolism 43:1196-1200, 1994
46. Shaish A, Daugherty A, O'Sullivan F, et al: Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits. J Clin Invest 96:2075-2082, 1995
47. Bowry VW, Stanley KK, Stocker R: High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc Natl Acad Sci USA 89:10316-10320, 1996